Detection of serum microRNAs from department of defense serum repository

Journal of Occupational and Environmental Medicine

Volumn 58, Issue 8S, 2016, Pages S62-S71

  Woeller, Collynn F ^a   Thatcher, Thomas H ^a   Van Twisk, Daniel ^a   Pollock, Stephen J ^a   Croasdell, Amanda ^a   Kim, Nina ^a   Hopke, Philip K ^b   Xia, Xiaoyan ^b   Thakar, Juilee ^a   Mallon, Timothy M ^c   Utell, Mark J ^a   Phipps, Richard P ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b CLARKSON UNIVERSITY   (United States)

^c Uniformed Services University of the Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; COTININE; CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MICRORNA; POLYCYCLIC AROMATIC HYDROCARBON; ANTHRACENE; EOTAXIN; FLT3 LIGAND; FLUORENE; FRACTALKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 5; MONOCYTE CHEMOTACTIC PROTEIN 1; NAPHTHALENE; PHENANTHRENE; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ARTICLE; BLOOD SAMPLING; DEPARTMENT OF DEFENSE SERUM REPOSITORY; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; GOVERNMENT; HEMOLYSIS; HUMAN; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MILITARY SERVICE; OCCUPATIONAL EXPOSURE; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TOBACCO; ARMY; CLINICAL DATA REPOSITORY; POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA ISOLATION; SMOKING; ANALYSIS; BLOOD; BLOOD BANK; RETROSPECTIVE STUDY; SOLDIER;

BIOMARKERS; BLOOD BANKS; COTININE; CYTOKINES; ENVIRONMENTAL EXPOSURE; HUMANS; IMMUNOGLOBULIN E; MICRORNAS; MILITARY PERSONNEL; OCCUPATIONAL EXPOSURE; POLYCYCLIC AROMATIC HYDROCARBONS; RETROSPECTIVE STUDIES;

EID: 84983350360     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0000000000000742     Document Type: Article

References (70)

1. Smith B, Wong CA, Boyko EJ, Phillips CJ, Gackstetter GD, Ryan MA, et al. The effects of exposure to documented open-Air burn pits on respiratory health among deployers of the Millennium Cohort Study. J Occup Environ Med. 2012;54:708-716.
2. Mancuso JD, Mallon TM, Gaydos JC. Maximizing the capabilities of the DoD serum repository to meet current and future needs, report of the needs panel. Mil Med. 2015;180(10 Suppl):13-24.
3. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215-233.
4. Grasedieck S, Scholer N, Bommer M, Niess JH, Tumani H, Rouhi A, et al. Impact of serum storage conditions on microRNA stability. Leukemia. 2012;26:2414-2416.
5. Mraz M, Malinova K, Mayer J, Pospisilova S. MicroRNA isolation and stability in stored RNA samples. Biochem Biophys Res Commun. 2009;390:1-4.
6. Iorio MV, Croce CM. microRNA involvement in human cancer. Carcinogenesis. 2012;33:1126-1133.
7. Ebrahimi A, Sadroddiny E. MicroRNAs in lung diseases: recent findings and their pathophysiological implications. Pulm Pharmacol Ther. 2015;34:55-63.
8. Cho Y, Song MK, Jeong SC, Lee K, Heo Y, Kim TS, et al. MicroRNA response of inhalation exposure to hexanal in lung tissues from Fischer 344 rats. Environ Toxicol;. 2015 [Epub ahead of print].
9. Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012;4:143-159.
10. Deng Q, Huang S, Zhang X, Zhang W, Feng J, Wang T, et al. Plasma microRNA expression and micronuclei frequency in workers exposed to polycyclic aromatic hydrocarbons. Environ Health Perspect. 2014;122:719-725.
11. Jensen SG, Lamy P, Rasmussen MH, Ostenfeld MS, Dyrskjot L, Orntoft TF, et al. Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs. BMC Genomics. 2011;12:435.
12. Arjomandi M, Wong H, Donde A, Frelinger J, Dalton S, Ching W, et al. Exposure to medium and high ambient levels of ozone causes adverse systemic inflammatory and cardiac autonomic effects. Am J Physiol Heart Circ Physiol. 2015;308:H1499-H1509.
13. Swiston JR, DavidsonW, Attridge S, Li GT, Brauer M, van Eeden SF.Wood smoke exposure induces a pulmonary and systemic inflammatory response in firefighters. Eur Respir J. 2008;32:129-138.
14. Cormier Y, Israel-Assayag E. Adiposity affects human response to inhaled organic dust. Am J Ind Med. 2006;49:281-285.
15. Quirce S. IgE antibodies in occupational asthma: are they causative or an associated phenomenon? Curr Opin Allergy Clin Immunol. 2014;14:100-105.
16. Eckl-Dorna J, Niederberger V. What is the source of serum allergen-specific IgE? Curr Allergy Asthma Rep. 2013;13:281-287.
17. Kamal A, Cincinelli A, Martellini T, Malik RN. A review of PAH exposure from the combustion of biomass fuel and their less surveyed effect on the blood parameters. Environ Sci Pollut Res Int. 2015;22:4076-4098.
18. Klingbeil EC, Hew KM, Nygaard UC, Nadeau KC. Polycyclic aromatic hydrocarbons, tobacco smoke, and epigenetic remodeling in asthma. Immunol Res. 2014;58:369-373.
19. Andersen CL, Jensen JL, Orntoft TF. Normalization of real-Time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64:5245-5250.
20. Max W, Sung HY, Shi Y. Who is exposed to secondhand smoke? Selfreported and serum cotinine measured exposure in the U.S., 1999-2006. Int J Environ Res Public Health. 2009;6:1633-1648.
21. Sirimanne SR, Barr JR, Patterson Jr. DG, Ma L. Quantification of polycyclic aromatic hydrocarbons and polychlorinated dibenzo-p-dioxins in human serum by combined micelle-mediated extraction (cloud-point extraction) and HPLC. Anal Chem. 1996;68:1556-1560.
22. Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, et al. Identification of miRNA changes in Alzheimer?s disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis. 2008;14:27-41.
23. Kanehisa M, Goto S, Sato Y, Kawashima M, Furumichi M, Tanabe M. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 2014;42(Database issue):D199-D205.
24. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27-30.
25. Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T. PID: the Pathway Interaction Database. Nucleic Acids Res. 2009;37(Database issue):D674-D679.
26. Blondal T, Jensby Nielsen S, Baker A, Andreasen D, Mouritzen P, Wrang Teilum M, et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods. 2013;59:S1-S6.
27. Thakar J, Hartmann BM, Marjanovic N, Sealfon SC, Kleinstein SH. Comparative analysis of anti-viral transcriptomics reveals novel effects of influenza immune antagonism. BMC Immunol. 2015;16:46.
28. Panteli KE, Hatzimichael EC, Bouranta PK, Katsaraki A, Seferiadis K, Stebbing J. Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases. Br J Haematol. 2005;130:709-715.
29. Kim KH, Jahan SA, Kabir E, Brown RJ. A review of airborne polycyclic aromatic hydrocarbons (PAHs) and their human health effects. Environ Int. 2013;60:71-80.
30. Farmer PB, Singh R, Kaur B, Sram RJ, Binkova B, Kalina I, et al. Molecular epidemiology studies of carcinogenic environmental pollutants. Effects of polycyclic aromatic hydrocarbons (PAHs) in environmental pollution on exogenous and oxidative DNA damage. Mutat Res. 2003;544:397-402.
31. Abraham JH, DeBakey SF, Reid L, Zhou J, Baird CP. Does deployment to Iraq and Afghanistan affect respiratory health of US military personnel? J Occup Environ Med. 2012;54:740-745.
32. Falvo MJ, Osinubi OY, Sotolongo AM, Helmer DA. Airborne hazards exposure and respiratory health of Iraq and Afghanistan veterans. Epidemiol Rev. 2015;37:116-130.
33. Kerr KJ. Gulf War illness: an overview of events, most prevalent health outcomes, exposures, and clues as to pathogenesis. Rev Environ Health. 2015;30:273-286.
34. Perdue CL, Cost AA, Rubertone MV, Lindler LE, Ludwig SL. Description and utilization of the United States department of defense serum repository: a review of published studies, 1985-2012. PLoS One. 2015;10:e0114857.
35. Ovchinnikova ES, Schmitter D, Vegter EL, Ter Maaten JM, Valente MA, Liu LC, et al. Signature of circulating microRNAs in patients with acute heart failure. Eur J Heart Fail;. 2015 [Epub ahead of print].
36. Sanfiorenzo C, Ilie MI, Belaid A, Barlesi F, Mouroux J, Marquette CH. Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PLoS One. 2013;8:e54596.
37. Leidinger P, Keller A, Borries A, Huwer H, Rohling M, Huebers J, et al. Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer. 2011;74:41-47.
38. Li Y, Kowdley KV. Method for microRNA isolation from clinical serum samples. Anal Biochem. 2012;431:69-75.
39. Mestdagh P, Hartmann N, Baeriswyl L, Andreasen D, Bernard N, Chen C, et al. Evaluation of quantitative miRNA expression platforms in the micro-RNA quality control (miRQC) study. Nat Methods. 2014;11:809-815.
40. Yamada A, Cox MA, Gaffney KA, Moreland A, Boland CR, Goel A. Technical factors involved in the measurement of circulating microRNA biomarkers for the detection of colorectal neoplasia. PLoS One. 2014;9: e112481.
41. MacLellan SA, MacAulay C, Lam S, Garnis C. Pre-profiling factors influencing serum microRNA levels. BMC Clin Pathol. 2014;14:27.
42. Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, van Zandwijk N. Haemolysis during sample preparation alters microRNA content of plasma. PLoS One. 2011;6:e24145.
43. Powell TM, Smith TC, Jacobson IG, Boyko EJ, Hooper TI, Gackstetter GD, et al. Prospective assessment of chronic multisymptom illness reporting possibly associated with open-Air burn pit smoke exposure in Iraq. J Occup Environ Med. 2012;54:682-688.
44. Jones KA, Smith B, Granado NS, Boyko EJ, Gackstetter GD, Ryan MA. Newly reported lupus and rheumatoid arthritis in relation to deployment within proximity to a documented open-Air burn pit in Iraq. J Occup Environ Med. 2012;54:698-707.
45. Maska LB, Sayles HR, O?Dell JR, Curtis JR, Bridges Jr. SL, Moreland LW, et al. Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012;64:1804-1810.
46. Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol. 2009;169:236-248.
47. Zaman MS, Thamminana S, Shahryari V, Chiyomaru T, Deng G, Saini S, et al. Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer. PLoS One. 2012;7:e50203.
48. Begum S, Hayashi M, Ogawa T, Jabboure FJ, Brait M, Izumchenko E, et al. An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: clinical significance of miR-23b-3p deregulation. Sci Rep. 2015;5:13236.
49. Li L, Li B, Chen D, Liu L, Huang C, Lu Z, et al. miR-139 and miR-200c regulate pancreatic cancer endothelial cell migration and angiogenesis. Oncol Rep. 2015;34:51-58.
50. Ebrahimi F, Gopalan V, Smith RA, Lam AK. miR-126 in human cancers: clinical roles and current perspectives. Exp Mol Pathol. 2014;96:98-107.
51. Chen Z, Liu X, Hu Z, Wang Y, Liu M, Liu X, et al. Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer. Oncol Lett. 2015;10:329-336.
52. Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-Alpha, IFNgamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm. 2005;2005:273-279.
53. Bostrom EA, Kindstedt E, Sulniute R, Palmqvist P, Majster M, Holm CK, et al. Increased eotaxin and MCP-1 levels in serum from individuals with periodontitis and in human gingival fibroblasts exposed to pro-inflammatory cytokines. PLoS One. 2015;10:e0134608.
54. George ML, Eccles SA, Tutton MG, Abulafi AM, Swift RI. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res. 2000;6:3147-3152.
55. Stelmach I, Jerzynska J, Kuna P. A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-Agonist treatment on IL-10 serum levels in children with asthma. Clin Exp Allergy. 2002;32:264-269.
56. Mastrangelo G, Clonfero E, Pavanello S, Fedeli U, Fadda E, Turato A. Exposure to diesel exhaust enhances total IgE in non-Atopic dockers. Int Arch Occup Environ Health. 2003;76:63-68.
57. Samuelsen M, Nygaard UC, Lovik M. Allergy adjuvant effect of particles from wood smoke and road traffic. Toxicology. 2008;246:124-131.
58. Kabesch M, Schedel M, Carr D, Woitsch B, Fritzsch C, Weiland SK, et al. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol. 2006;117:269-274.
59. Joseph CL, Havstad S, Bobbitt K, Woodcroft K, Zoratti EM, Nageotte C, et al. Transforming growth factor beta (TGFbeta1) in breast milk and indicators of infant atopy in a birth cohort. Pediatr Allergy Immunol. 2014;25:257-263.
60. Kypriotou M, Rivero D, Haller S, Mariotto A, HuberM, Acha-Orbea H, et al. Activin a inhibits antigen-induced allergy in murine epicutaneous sensitization. Front Immunol. 2013;4:246.
61. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 2009;23:2839-2849.
62. Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell. 2008;133:217-222.
63. Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J, et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol. 2008;9:405-414.
64. Danielson LS, Reavie L, Coussens M, Davalos V, Castillo-Martin M, Guijarro MV. Limited miR-17-92 overexpression drives hematologic malignancies. Leuk Res. 2015;39:335-341.
65. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 2005;65:9628-9632.
66. Bommel H, Haake M, Luft P, Horejs-Hoeck J, Hein H, Bartels J, et al. The diesel exhaust component pyrene induces expression of IL-8 but not of eotaxin. Int Immunopharmacol. 2003;3:1371-1379.
67. Miller RL, Garfinkel R, Lendor C, Hoepner L, Li Z, Romanoff L, et al. Polycyclic aromatic hydrocarbon metabolite levels and pediatric allergy and asthma in an inner-city cohort. Pediatr Allergy Immunol. 2010;21(2 Pt 1):260-267.
68. Jude JA, Dileepan M, Subramanian S, Solway J, Panettieri Jr. RA, Walseth TF. miR-140-3p regulation of TNF-Alpha-induced CD38 expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2012;303:L460-L468.
69. Rah SY, Park KH, Han MK, Im MJ, Kim UH. Activation of CD38 by interleukin-8 signaling regulates intracellular Ca2R level and motility of lymphokine-Activated killer cells. J Biol Chem. 2005;280:2888-2895.
70. Guedes AG, Jude JA, Paulin J, Kita H, Lund FE, Kannan MS. Role of CD38 in TNF-Alpha-induced airway hyperresponsiveness. Am J Physiol Lung Cell Mol Physiol. 2008;294:L290-L299.